» Articles » PMID: 18298653

Adipose Stem Cells for Intervertebral Disc Regeneration: Current Status and Concepts for the Future

Overview
Journal J Cell Mol Med
Date 2008 Feb 27
PMID 18298653
Citations 40
Authors
Affiliations
Soon will be listed here.
Abstract

New regenerative treatment strategies are being developed for intervertebral disc degeneration of which the implantation of various cell types is promising. All cell types used so far require in vitro expansion prior to clinical use, as these cells are only limited available. Adipose-tissue is an abundant, expendable and easily accessible source of mesenchymal stem cells. The use of these cells therefore eliminates the need for in vitro expansion and subsequently one-step regenerative treatment strategies can be developed. Our group envisioned, described and evaluated such a one-step procedure for spinal fusion in the goat model. In this review, we summarize the current status of cell-based treatments for intervertebral disc degeneration and identify the additional research needed before adipose-derived mesenchymal stem cells can be evaluated in a one-step procedure for regenerative treatment of the intervertebral disc. We address the selection of stem cells from the stromal vascular fraction, the specific triggers needed for cell differentiation and potential suitable scaffolds. Although many factors need to be studied in more detail, potential application of a one-step procedure for intervertebral disc regeneration seems realistic.

Citing Articles

High impact works on stem cell transplantation in intervertebral disc degeneration.

Chen X, Li H, Huang B, Ruan J, Li X, Li Q BMC Musculoskelet Disord. 2024; 25(1):1029.

PMID: 39702055 PMC: 11660786. DOI: 10.1186/s12891-024-08131-4.


Mapping knowledge structure and themes trends of non-surgical treatment in intervertebral disc degeneration.

Zhao Y, Xia Q, Zhu L, Xia J, Xiang S, Mao Q Heliyon. 2024; 10(17):e36509.

PMID: 39286189 PMC: 11402762. DOI: 10.1016/j.heliyon.2024.e36509.


Role of non‑coding RNAs in cartilage endplate (Review).

Zhao X, Yuan J, Jia J, Zhang J, Liu J, Chen Q Exp Ther Med. 2023; 26(1):312.

PMID: 37273754 PMC: 10236100. DOI: 10.3892/etm.2023.12011.


Preclinical in vivo animal models of intervertebral disc degeneration. Part 1: A systematic review.

Poletto D, Crowley J, Tanglay O, Walsh W, Pelletier M JOR Spine. 2023; 6(1):e1234.

PMID: 36994459 PMC: 10041387. DOI: 10.1002/jsp2.1234.


Barriers to mesenchymal stromal cells for low back pain.

Peng B, Yan X World J Stem Cells. 2023; 14(12):815-821.

PMID: 36619693 PMC: 9813839. DOI: 10.4252/wjsc.v14.i12.815.


References
1.
Smit T, Krijnen M, van Dijk M, Wuisman P . Application of polylactides in spinal cages: studies in a goat model. J Mater Sci Mater Med. 2006; 17(12):1237-44. DOI: 10.1007/s10856-006-0597-5. View

2.
Discher D, Janmey P, Wang Y . Tissue cells feel and respond to the stiffness of their substrate. Science. 2005; 310(5751):1139-43. DOI: 10.1126/science.1116995. View

3.
Gibson J, Waddell G . Surgery for degenerative lumbar spondylosis: updated Cochrane Review. Spine (Phila Pa 1976). 2005; 30(20):2312-20. DOI: 10.1097/01.brs.0000182315.88558.9c. View

4.
Moore K, Lemischka I . Stem cells and their niches. Science. 2006; 311(5769):1880-5. DOI: 10.1126/science.1110542. View

5.
Kern S, Eichler H, Stoeve J, Kluter H, Bieback K . Comparative analysis of mesenchymal stem cells from bone marrow, umbilical cord blood, or adipose tissue. Stem Cells. 2006; 24(5):1294-301. DOI: 10.1634/stemcells.2005-0342. View